Study of Nasonex® in Improving Sleep Disturbances Related to Perennial Allergic Rhinitis (Study P04909)(TERMINATED)
Status:
Terminated
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
This study will hope to show that the treatment of the patient's perennial allergic rhinitis
(PAR) using Nasonex® (mometasone furoate nasal spray) will result in improvement of the nasal
symptoms of PAR and of nighttime sleep-disordered breathing, thereby resulting in improved
sleep quality, less daytime sleepiness, improved daytime functioning, and improved quality of
life.